Claroid Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Daskroi, Gujarat, India, established in 2018.
2018 Daskroi, Gujarat, India Active
Last Updated:
Access Report
About Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited, a active public limited company, was established on 31 August 2018 in Daskroi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304GJ2018PLC103796. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹15.00 Cr.

Employing 31 professional, Its leadership includes Rushin Baijubhai Desai (Whole-Time Director), Arpankumar Patel (Director), Ghanshyam Arjanbhai Patel (Director). Past directors included Rushin Baijubhai Desai, Arpankumar Patel, Ghanshyam Arjanbhai Patel. It holds ₹33.83 Cr open charges and no settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at S.No-217/P, Opp Gurukul English School,, Kamod-Pirana Road,, Daskroi, Gujarat, 382425.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304GJ2018PLC103796

  • Registration Number

    103796

  • Incorporation Date

    31 August 2018

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹15.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 15.00 Cr
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 33.83 Cr
  • Revenue Growth **** 55.13%
  • Profit Growth **** 290.94%
  • Ebitda **** 93.35%
  • Net Worth 1779.59%
  • Total Assets **** 6.54%
Company report

Claroid Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Claroid Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Claroid Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Rushin Baijubhai Desai Whole-Time Director 31 Aug 2018 Current
Arpankumar Patel Director 28 Apr 2025 Current
Ghanshyam Arjanbhai Patel Director 31 Aug 2018 Current
Snehalkumar Hasmukhlal Soni Whole-Time Director 31 Aug 2018 Current
Shailesh Arjanbhai Patel Whole-Time Director 31 Aug 2018 Current
Shashwat Yatishkumar Shah Director 28 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 May 2025 Past
Pramod Abcsdd Additional Director 30 Jul 2025 Past
Pramod Abcsdd Director 19 May 2025 Past
Pramod Abcsdd Director 19 May 2025 Past
Pramod Abcsdd Director 19 May 2025 Past
Pramod Abcsdd Director 01 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Claroid Pharmaceuticals.

Claroid Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 55.13% increase. The company also saw a substantial improvement in profitability, with a 290.94% increase in profit. The company's net worth Soared by an impressive increase of 1779.59%.

Claroid Pharmaceuticals revenue growth over time
Claroid Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 55.13%
*******
*******
*******
*******
Revenue from Operations
*******
 61.15%
*******
*******
*******
*******
Total Assets
*******
 6.54%
*******
*******
*******
*******
Profit or Loss
*******
 290.94%
*******
*******
*******
*******
Net Worth
*******
 1779.59%
*******
*******
*******
*******
EBITDA
*******
 93.35%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Claroid Pharmaceuticals?

In 2024, Claroid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹338,328,042.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 33.83 Cr
Latest Charge Details
Date Lender Amount Status
03 Feb 2020 Hdfc Bank Limited ₹33.83 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Claroid Pharmaceuticals?

Claroid Pharmaceuticals has a workforce of 31 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Claroid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claroid Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Claroid Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Megha Parikh was appointed as a Company Secretary was appointed as a Company Secretary on 02 Aug 2025 & has been associated with this company since 9 months 25 days . was documented.

  • Annual General Meeting

    The activity Claroid Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was completed.

  • Director Appointment

    Baiju Bhupendrabhai Desai was appointed as a Cfo was appointed as a Cfo on 19 Jun 2025 & has been associated with this company since 11 months 8 days . was recorded as a recent event.

  • Director Appointment

    Progress on Baiju Bhupendrabhai Desai was appointed as a CFO was appointed as a CFO on 20 May 2025 & has been associated with this company since 1 year 7 days . was documented.

  • Director Appointment

    Arpankumar Patel was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 29 days . was recorded as a recent event.

  • Director Appointment

    Progress on Shashwat Yatishkumar Shah was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 29 days . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Claroid Pharmaceuticals Limited?

The CIN of Claroid Pharmaceuticals Limited is U24304GJ2018PLC103796.

Where is Claroid Pharmaceuticals Limited headquartered?

Claroid Pharmaceuticals Limited is headquartered at S.No-217/P, Opp Gurukul English School,, Kamod-Pirana Road,, Daskroi, Gujarat, 382425.

When was Claroid Pharmaceuticals Limited incorporated?

Claroid Pharmaceuticals Limited was incorporated on 31 August 2018.

Who are the current directors of Claroid Pharmaceuticals Limited?

The current directors of Claroid Pharmaceuticals Limited are

What is the primary industry of Claroid Pharmaceuticals Limited?

The primary industry of Claroid Pharmaceuticals Limited is Manufacturing.

Is Claroid Pharmaceuticals Limited a listed company?

Claroid Pharmaceuticals Limited is unlisted.

What is the capital structure of Claroid Pharmaceuticals Limited?

The authorized capital of Claroid Pharmaceuticals Limited is ₹25.00 Cr, and the paid-up capital is ₹15.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available